menu
    • menu

    Company profile for Neuronetics

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neuronetics, Inc. believes that mental health is as important as physical health. We take a patient-centric approach to designing, developing, and marketing products that improve quality of life for people who suffer from psychiatric disorders.An FDA-cleared, non-drug, non-invasive treatment for people with depression, Neuronetics’ NeuroStar® Advanced Therapy system is the leading TMS (transcranial magnetic stimulation) tre...
    Neuronetics, Inc. believes that mental health is as important as physical health. We take a patient-centric approach to designing, developing, and marketing products that improve quality of life for people who suffer from psychiatric disorders.An FDA-cleared, non-drug, non-invasive treatment for people with depression, Neuronetics’ NeuroStar® Advanced Therapy system is the leading TMS (transcranial magnetic stimulation) treatment for major depressive disorder.NeuroStar delivers a unique form of TMS proven to help patients achieve lasting remission from depression symptoms.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuroneticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3222 Phoenixville Pike Malvern, PA 19355
    Telephone
    Telephone
    877-600-7555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neurostar.com/neuronetics/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neuronetics-inc./
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/tmstherapy

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neuronetics Reports Q1 2026 Results, Hosts Earnings Call
    Neuronetics Reports Q1 2026 Results, Hosts Earnings Call

    21 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/21/3277931/0/en/neuronetics-to-report-first-quarter-2026-financial-and-operating-results-and-host-conference-call.html

    GLOBENEWSWIRE
    21 Apr 2026
    Share Share
    Optum Expands NeuroStar TMS Coverage to PMHNPs
    Optum Expands NeuroStar TMS Coverage to PMHNPs

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272510/0/en/Optum-United-Healthcare-United-Behavioral-Health-Expands-NeuroStar-TMS-Coverage-to-Include-Psychiatric-Mental-Health-Nurse-Practitioners.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share
    Neuronetics Comments On Letter From Pointillist Family Office
    Neuronetics Comments On Letter From Pointillist Family Office

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3268974/0/en/Neuronetics-Comments-on-Letter-from-Pointillist-Family-Office.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Neuronetics Announces Chief Financial Officer Transition
    Neuronetics Announces Chief Financial Officer Transition

    06 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/06/3268731/0/en/Neuronetics-Announces-Chief-Financial-Officer-Transition.html

    GLOBENEWSWIRE
    06 Apr 2026
    Share Share
    Neuronetics Unveils 2025 Q4 And Full-Year Financial Results
    Neuronetics Unveils 2025 Q4 And Full-Year Financial Results

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257056/0/en/Neuronetics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-and-Operating-Results.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Neuronetics Names Dan Reuvers President & CEO
    Neuronetics Names Dan Reuvers President & CEO

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257052/0/en/Neuronetics-Appoints-Dan-Reuvers-as-President-and-Chief-Executive-Officer.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search